Article Text
Therapeutics
Continuing alendronate for an additional 5 years maintained bone mineral density in postmenopausal women
Statistics from Altmetric.com
Footnotes
-
↵* See glossary.
-
For correspondence: Dr D M Black, University of California, San Francisco, CA, USA. dblack{at}psg.ucsf.edu
-
Source of funding: Merck & Co.